Abstract
It is now fully accepted that Graves’ ophthalmopathy is an orbital autoimmune disease closely related to Graves’ disease and, less commonly, found in autoimmune hypothyroidism (1). These clinical features have led to the hypothesis, discussed at length elsewhere in this volume, that ophthalmopathy is the result of an autoimmune response against one or more orbital autoantigens which are shared by the thyroid. Such antigenic cross-reactivity would explain the known clinical associations and temporal features of the disease but it should still be recognized that any such cross-reactivity could be at the T cell rather than B cell level, and that, so far, this is still not a firmly established fact. Indeed, it remains the case that establishing the nature of autoantigen(s) responsible for ophthalmopathy is the Holy Grail of research in this area, as knowledge of the autoantigen responsible for an autoimmune disease is key to any experiments designed to map pathogenic epitopes or to any autoantigen-based therapeutic endeavors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Burch, H.B. and Wartofsky, L. 1993. Graves’ ophthamopathy: current concepts regarding pathogenesis and management. Endocrine Rev. 14:747–93.
Henderson, J. and Wall, J.R. 1981. Failure of haemagglutination and immunofluorecence methods to detect serum orbital antibodies in patients with Graves’ ophthalmopathy. Clin. Endocrinol. 14:153–8.
Mengistu, M., Laryea, E., Miller, A. and Wall, J.R. 1986. Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence. Clin. Exp. Immunol. 65:19–27.
Konishi, J., Herman, M.N. and Kriss, J.P. 1974. Binding of thyroglobulin and thyroglobulin - antithyroglobulin complex to extraocular muscle membrane. Endocrinology 95:434–66.
Kriss, J.P. 1970. Radioisotopic thyroidolyphography in patients with Graves’ disease. J. Clin. Endocrinol. Metab. 40:872–5.
Kodama, K., Sikorska, H., Bayly, R., Bandy-Dafoe, P. and Wall, J.R. 1984. Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 59:67–73.
Kuroki, T., Ruf, J., Whelan, L., Miller, A. and Wall, J.R. 1985. Anti-thyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders. Clin. Exp. Immunol. 62:361–70.
Tao, T.W., Cheng, P.J., Pham, H., Leu, S.L. and Kriss, J.P. 1986. Monoclonal antithyroglobulin antbodies derived from immunizations of mice with human eye muscle and thyroid membranes. J. Clin. Endocrinol. Metab. 63:577–82.
Kodama, K., Sikorska, H., Bandy-Dafoe, P., Bayly, R. and Wall, J.R. 1982. Demonstration of a circulating autoantibody against a soluble eye muscle antigen in Graves’ ophthalmopathy. Lancet ii:1353–6.
Salvi, M., Bingoye, F., Chung, F. and Wall, J.R. 1988. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 66:939–45.
Atkinson, S., Holcombe, M. and Kendall-Taylor, P. 1984. Ophthalmopathic immunoglobulin in patients with Graves’ ophthalmopathy. Lancet ii:374–6.
Kadlubowski, M., Irvine, W.J. and Rowland, C.A. 1986. The lack of specificity of ophthalmic immunoglobulins in Graves’ disease. J. Clin. Endocrinol. Metab. 63:990–5.
Ahmann, A., Baker, J.R., Weetman, A.P., Wartofsky, L., Nutman, T.B. and Burman, K.D. 1987. Antibodies to porcine eye muscle in patients with Graves’ ophthalmopathy: identification of serum immunoglobulin directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. J. Clin. Endocrinol. Metab. 64:454–60.
Miller, A., Sikorska, H., Salvi, M. and Wall, J.R. 1986. Evaluation of an enzyme-linked immunosorbent assay for the measurement of autoantibodies against eye muscle antigens in Graves’ ophthalmopathy. Acta Endocrinol. 113:514–22.
Weetman, A.P., Fells, P. and Shine, B. 1989. T and B cell reactivity to extraocular and skeletal muscle in Graves’ ophthalmopathy. Brit. J. Ophthal. 73:323–7.
Schifferdecker, E., Ketzler-Sasse, U., Boehm, B.O., Ronsheimer, H.B., Shcerbaum, W.A. and Schoffling, K. 1989. Re-evaluation of eye muscle autoantibody determination in Graves’ ophthalmopathy: failure to detect a specific antigen by use of enzyme-linked immunoblotting techniques. Acta Endocrinol. 121:643–50.
Salvi, M., Hiromatsu, Y., Bernard, N., How, J. and Wall, J.R. 1988. Human orbital tissue and thyroid membrane express a 64kDa protein which is recognized by autoantibodies in serum of patients with thyroid-associated ophthalmopathy. FEBS Lett. 232:125–9.
Salvi, M., Bernard, N., Miller, A., Zhang, Z-G, Gardini, E. and Wall, J.R. 1991. Prevalence of antibodies reactive with a 64kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Thyroid 1:207–13.
Bernard, N.F., Ertung, F., Teboul, N., Zhang, Z-G, Salvi, M. and Wall, J.R. 1991. Isotype and immunoglobulin subclass distribution of eye muscle membrane reactive antibodies in the serum of patients with thyroid-associated ophthalmopathy as detected in Western blotting. Autoimmunity 10:57–63.
Miller, A., Arthurs, B., Boucher, A., Liberman, A., Bernard, N., Rodien, P., Salvi, M. and Wall, J.R. 1992. Significance of antibodies reactive with a 64kDa eye muscle membrane antigen in patients with thyroid autoimmunity. Thyroid 2:197–202.
Weightman, D. and Kendall-Taylor, P. 1989. Cross-reaction of eye muscle antibodies with thyroid-tissue in thyroid-associated ophthalmopathy. J. Endocrinol. 122:201–6.
Kendler, D.L., Rootman, J., Huber, G.K. and Davies, T.F. 1991. A 64kD membrane antigen is a recurrent epitope for natural autoantibodies in patients with Graves’ thyroid and ophthalmic diseases. Clin. Endocrinol. 35:539–47.
Chang, T.C., Chang, T.J., Huang, Y.S., Su, R.J. and Kao, S.C.S. 1992. Identification of autoantigen recognized by autoimmune ophthalmopathy sera with immunoblotting correlated with orbital computed tomography. Clin. Immunol. Immunopathol. 65:161–6.
Hiromatsu, Y., Sato, M., Tanaka, K., Shoji, S., Nonaka, K., Chinami, M. and Fukazawa, H. 1992. Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative Western blot. Autoimmunity 14:9–16.
Tandon, N., Yan, S.L., Arnold, K., Metcalfe, R.A. and Weetman, A.P. 1994. Immunoglobulin class and subclass distribution of eye muscle and fibroblast antibodies in patients with thyroid-associated ophthalmopathy. Clin. Endocrinol. 40:629–39.
Wu, Y-J, Clarke, S.E.M. and Shepherd, P. 1998. Prevalence and significance of antibodies reactive with eye muscle membrane anrigens in sera from patients with Graves’ ophthalmopathy and other thyroid and nonthyroid disorders. Thyroid 8:167–74.
Wall, J.R., Hayes, M., Scalise, D., Stolarski, C., Nebes, V., Kiljanski, J., Salvi, M. and Sato, M. 1995. Native gel electrophoresis and isoelectric focusing of a 64kilodalton eye muscle protein shows that it is an important target for serum autoantibodies in patients with thyroid-associated ophthalmopathy and not expressed in other skeletal muscle. J. Clin. Endocrinol. Metab. 80:1226–32.
Dong, Q., Ludgate, M. and Vassart, G. 1991. Cloning and sequencing of a novel 64kDa autoantigen recognized by patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 72:1375–81.
Zhang, Z-G, Dong, Q., Rodien, P., Alcalde, L., Bernard, N., Boucher, A., Salvi, M., Arthurs, B., Vassart, G.M., Ludgate, M. and Wall, J.R. 1992. Antibodies in the serum of patients with autoimmune thyroid disorders react with a recombinant 98 amino acid fragment of a full length 64 kDa eye muscle membrane protein which is also expressed in the thyroid. Autoimmunity 13:151–7.
Ross, P.V., Koenig, R.J., Arscott, P., Ludgate, M., Waier, M., Nelson, C.C., Kaplan, M.M. and Baker Jr, J.R. 1993. Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 77:433–8.
Bernard, N.F., Nygen, T.N., Tyutyunikov, A., Stolarski, C., Scalise, D., Genovese, C., Hayes, M.B., Ludgate, M. and Wall, J.R. 1994. Antibodies against1D, a recombinant 64-kDa membrane protein, are associated with ophthalmopathy in patients with thyroid autoimmunity. Clin. Immunol. Immunopathol. 70:225–33.
Kromminga, A., Hagel, C., Arndt, R. and Schuppert, F. 1998. Serological reactivity of recombinant ID autoantigen and its expression in human thyroid and eye muscle tissue: A possible autoantigenic link in Graves’ patients. J. Clin. Endocrinol. Metab. 83:2817–23.
Kubota, S., Gunji, K., Stolarski, C., Kennerdell, J.S. and Wall, J. 1998. Reevaluation of the prevalences of serum autoantibodies reactive with “64-kd eye muscle proteins” in patients with thyroid-associated ophthalmopathy. Thyroid 8:175–9.
Kubota, S., Gunji, K., Ackrell, B.A.C., Cochran, G., Stolarski, C, Wengrowicz, S., Kennerdell, J.S., Hiromatsu, Y. and Wall, J. 1998. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: The corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves’ hyperthyroidism. J. Clin. Endocrinol. Metab. 83:443–7.
Gunji, K., De Bellis, A., Kubota, S., Swanson, J., Wengrowicz, S., Cochran, B., Ackrell, B.A.C., Salvi, M., Bellastella, A., Bizzarro, A., Sinisi, A.A. and Wall, J.R. 1999. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves’ hyperthyroidism. J. Clin. Endocrinol. Metab. 84:1255–62.
Joffe, B., Gunji, K., Panz, V., Zouvanis, M., Swanson, J., Ackrell, B.A.C. and Wall, J.R. 1998. Thyroid-associated ophthalmopathy in black South African patients with Graves’ disease: Relationship to antiflavoprotein antibodies. Thyroid 8: 1023–7.
Kemp, E.H., Ridgway, J.N., Smith, K.A., Watson, P.F. and Weetman, A.P., 2000. Autoantibodies in the flavoprotein subunit of succinate dehydrogenase: Analysis of specificity in autoimmune thyroid disease. Clin. Endocrinol. (in press).
Kadluboswki, M., Irvine, W.J. and Rowland, A.C. 1987. Anti-muscle antibodies in Graves’ ophthalmopathy. J. Clin. Lab. Immunol. 24:105–11.
Ludgate, M., Dong, Q., Dreyfus, P.A., Zakut, H., Taylor, P., Vassart, G. and Soreq, H. 1989. Definition, at the molecular level, of a thyroglobulin-acetylcholinesterase shared epitope: Study of its pathophysiological significance in patients with Graves’ ophthalmopathy. Autoimmunity 3:167–76.
Weetman, A.P., Tse, C.K., Randall, W.R., Tsim, K.W.K. and Barnard, E.A. 1988. Acetylcholinesterase antibodies and thyroid autoimmunity. Clin. Exp. Immunol. 71:96–9.
Mappouras, D.G., Philippou, G., Haralambous, S., Tzartos, S.J., Balafas, A., Souvatzoglou, A. and Lymberi, P. 1995. Antibodies to acetylcholinesterase cross-linking with thyroglobulin in myasthenia gravis and Graves’ disease. Clin. Exp. Immunol. 100:336–43.
Brimijoin, S. and Lennon, V.A. 1990. Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies. Proc. Natl. Acad. Sci. USA 87:9630–4.
Elisei, R., Weightman, D., Kendall-Taylor, P., Vassart, G. and Ludgate, M. 1993. Muscle autoantigens in thyroid associated ophthalmopathy: The limits of molecular genetics. J. Endocrinol. Invest. 16:533–40.
Gunji, K., De Bellis, A., Li, A.W., Yamada, M., Kubota, S., Ackrell, G., Wengrowicz, S., Bellastella, A., Bizzarro, A., Sinisi, A. and Wall, J.R. 2000. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: Autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves’ hyperthyroidism. J. Clin. Endocrinol. Metab. 85:1641–7.
Bahn, R.S., Gorman, C.A., Johnson, C.M. and Smith, T.J. 1989. Presence of antibodies in the sera of patients with Graves’ disease recognizing a 23 kilodalton fibroblast protein. J. Clin. Endocrinol. Metab. 69:622–8.
Stover, C., Otto, E., Beyer, J. and Kahaly, G. 1992. Humoral immunity and retrobulbar fibroblasts in endocrine ophthalmopathy. Acta Endocrinol. 126:394–402.
Molnar, I. and Balázs, C.S. 1991. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves’ ophthalmopathy. Acta Medical Hungarica 48:13–21.
Arnold, K., Metcalfe, R. and Weetman, A.P. 1995. Immunoglobulin A class fibroblast antibodies in patients with Graves’ disease and prebitial myxedema. J. Clin. Endocrinol. Metab. 80:3430–7.
Bednarczuk, T., Stolarski, C., Pawlik, E., Slon, M., Rowinski, M., Kubota, S., Hiromatsu, Y., Bartoszewicz, Z., Wall, J.R. and Nauman, J. 1999. Autoantibodies reactive with extracellular matrix proteins in patients with thyroid-associated ophthalmopathy. Thyroid 9:289–95.
Perros, P. and Kendall-Taylor, P. 1992. Biological activity of autoantibodies from patients with thyroid-associated ophthalmopathy: In vitro effects on porcine extraocular myoblasts. Q. J. Med. 84:691–706.
Weightman, D.R., Perros, P., Sherif, I.H. and Kendall-Taylor, P. 1993. Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy. Autoimmunity 16:251–7.
Rotella, C.M., Zonefrati, R., Toccafondi, R., Valente, W.A. and Kohn, L.D. 1986. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: An assay which appears to measure exophthalmogenic immunoglobulins in Graves’ sera. J. Clin. Endocrinol. Metab. 62:357–67.
Metcalfe, R.A., Davies, R. and Weetman, A.P. 1993. Analysis of fibroblast-stimulating activity in IgG from patients with Graves’ dermopathy. Thyroid 3:207–12.
Wall, J.R., Strakosch, C.R., Fang, S.L., Ingbar, S.H. and Braverman, L.E. 1979. Thyroid binding antibodies and other immunological abnormalities in patients with Graves’ ophthalmopathy: Effect of treatment with cyclophosphamide. Clin. Endocrinol. 10:79–91.
McLachlan, S.M., Bahn, R. and Rapoport, B. 1992. Endocrine ophthalmopathy: A re-evaluation of the association with thyroid autoantibodies. Autoimmunity 14:143–8.
Nishikawa, M., Yoshimura, M., Toyoda, N., Masuki, H., Yonemoto, T., Gondou, A., Kato, T., Kurokawa, H., Furumura, T. and Inada, M. 1993. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves’ ophthalmopathy. Acta Endocrinol. 129:213–9.
Kasagi, K., Hidaka, A., Nakamura, H., Takeuchi, R., Misaki, T., Iida, Y. and Konishi, J. 1993. Thyrotropin receptor antibodies in hypothyroid Graves’ disease. J. Clin. Endocrinol. Metab. 76:504–8.
Feliciello, A., Procellini, A., Ciullo, I., Vonavolontà, G., Avvedimento, E.V. and Fenzi, G. 1993. Expression of thyrotropin-receptor mRNA in healthy and Graves’ disease retro-orbital tissue. Lancet 342:337–338.
Heufelder, A.E. 1995. Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves’ ophthalmopathy. Thyroid 5:331–40.
Aust, G., Crisp, M., Bösenberg, E., Ludgate, M., Weetman, A.P. and Paschke, R. 1998. Transcription of thyroid autoantigens in non-expressing tissues. Exp. Clin. Endocrinol. Diab. 106:319–23.
Paschke, R., Metcalfe, A., Alcalde, L., Vassart, G., Weetman, A. and Ludagete, M. 1994. Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues. J. Clin. Endocrinol. Metab. 79:1234–8.
Burch, H.B., Sellitti, D., Barnes, S.G., Nagy, E.V., Bahn, R.S. and Burman, K.D. 1994. Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 78:1384–91.
Spitzweg, C., Joba, W., Hunt, N. and Heufelder, A.R. 1997. Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue. Soc. Eur. J. Endocrinol. 136:599–607.
Dutton, C.M., Joba, W., Spitzweg, C., Heufelder, A.E. and Bahn, R.S. 1997. Thyrotropin receptor expression in adrenal, kidney and thymus. Thyroid 7:879–83.
Endo, T., Ohta, K., Haraguchi, K. and Onaya, T. 1995. Cloning and functional expression of a thyrotropin receptor cDNA from fat red cells. J. Biol. Chem. 270:10833–7.
Crisp, M.S., Lane, C., Halliwell, M., Wynford-Thomas, D. and Ludgate, M. 1997. Thyrotropin receptor transcripts in human adipose tissue. J. Clin. Endocrinol. Metab. 82:2003–5.
Bahn, R.S., Dutton, C.M., Natt, N., Joba, W., Spitzweg, C. and Heufelder, A.E. 1998. Thyrotropin receptor expression in Graves’ orbital adipose/connective tissues: Potential autoantigen in Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 83:998–1002.
Bahn, R.S., Dutton, C.M., Joba, W. and Heufelder, A.E. 1998. Thyrotropin receptor expression in cultured Graves’ orbital preadipocyte fibroblasts is stimulated by thyrotropin. Thyroid 8:193–6.
Many, M-C, Costaliola, S., Detrait, M., Denef, J-F, Vassart, G. and Ludgate, M. 1999. Development of an animal model of autoimmune thyroid eye disease. J. Immunol. 162:4966–74.
Mullin, B.R., Levinson, R.E., Friedman, A., Henson, D.E., Winand, R.J. and Kohn, L.D. 1977. Delayed hypersensitivity in Graves’ disease and exophthalmos: Identification of thyroglobulin in normal human orbital muscle. Endocrinology 100:351–66.
Weetman A.P. 1992. The role of T lymphocytes in thyroid-associated ophthalmopathy. Autoimmunity 13:69–73.
Arnold, K., Tandon, N., McIntosh, R.S., Elisei, R., Ludgate, M. and Weetman, A.P. 1994. T cell responses to orbital antigens in thyroid-associated ophthalmopathy. Clin. Exp. Immunol. 96:329–34.
Stover, C., Otto, E., Beyer, J. and Kahaly, G. 1994. Cellular immunity and retrobulbar fibroblasts in Graves’ ophthalmopathy. Thyroid 4:161–5.
Grubeck-Loebenstein, B., Trieb, K., Sztankay, A., Holter, W., Anderl, H. and Wick, G. 1994. Retrobulbar T cells from patients with Graves’ ophthalmopathy are CD8+and specifically recognize autologous fibroblasts. J. Clin. Invest. 93:2738–43.
Otto, E.A., Ochs, K., Hansen, C., Wall, J.R. and Kahaly, G.J. 1996. Orbital tissue-derived T lymphocytes from patients with Graves’ ophthalmopathy recognize autologous orbital antigens. J. Clin. Endocrinol. Metab. 81:3045–50.
Pappa, A., Calder, V., Ajjan, R., Fells, P., Ludgate, M., Weetman, A.P. and Lightman, S. 1997. Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO). Clin. Exp. Immunol. 109:362–9.
Jaume, J.C., Portolano, S., Prummel, M.F., McLachlan, S.M. and Rapoport, B. 1994. Molecular cloning and characterization of genes for antibodies generated by orbital tissue-infiltrating B-cells in Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 78:348–52.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Weetman, A.P., Kemp, E.H., Ridgway, J.N., Watson, P.F. (2001). Orbital Autoantigens. In: Bahn, R.S. (eds) Thyroid Eye Disease. Endocrine Updates, vol 14. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1447-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1447-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5558-8
Online ISBN: 978-1-4615-1447-3
eBook Packages: Springer Book Archive